BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18386139)

  • 1. Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California.
    Parikh-Patel A; White RH; Allen M; Cress R
    Cancer Causes Control; 2008 Oct; 19(8):887-94. PubMed ID: 18386139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study.
    Westermann R; Zobbe K; Cordtz R; Haugaard JH; Dreyer L
    Lupus; 2021 Apr; 30(5):752-761. PubMed ID: 33497306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.
    Dreyer L; Faurschou M; Mogensen M; Jacobsen S
    Arthritis Rheum; 2011 Oct; 63(10):3032-7. PubMed ID: 21953088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer risk in systemic lupus: an updated international multi-centre cohort study.
    Bernatsky S; Ramsey-Goldman R; Labrecque J; Joseph L; Boivin JF; Petri M; Zoma A; Manzi S; Urowitz MB; Gladman D; Fortin PR; Ginzler E; Yelin E; Bae SC; Wallace DJ; Edworthy S; Jacobsen S; Gordon C; Dooley MA; Peschken CA; Hanly JG; Alarcón GS; Nived O; Ruiz-Irastorza G; Isenberg D; Rahman A; Witte T; Aranow C; Kamen DL; Steinsson K; Askanase A; Barr S; Criswell LA; Sturfelt G; Patel NM; Senécal JL; Zummer M; Pope JE; Ensworth S; El-Gabalawy H; McCarthy T; Dreyer L; Sibley J; St Pierre Y; Clarke AE
    J Autoimmun; 2013 May; 42():130-5. PubMed ID: 23410586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An international cohort study of cancer in systemic lupus erythematosus.
    Bernatsky S; Boivin JF; Joseph L; Rajan R; Zoma A; Manzi S; Ginzler E; Urowitz M; Gladman D; Fortin PR; Petri M; Edworthy S; Barr S; Gordon C; Bae SC; Sibley J; Isenberg D; Rahman A; Aranow C; Dooley MA; Steinsson K; Nived O; Sturfelt G; Alarcón G; Senécal JL; Zummer M; Hanly J; Ensworth S; Pope J; El-Gabalawy H; McCarthy T; St Pierre Y; Ramsey-Goldman R; Clarke A
    Arthritis Rheum; 2005 May; 52(5):1481-90. PubMed ID: 15880596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of cancer among rheumatoid arthritis patients in California.
    Parikh-Patel A; White RH; Allen M; Cress R
    Cancer Causes Control; 2009 Aug; 20(6):1001-10. PubMed ID: 19184473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of malignancy in patients with systemic lupus erythematosus: population-based cohort study in Korea.
    Han JY; Kim H; Jung SY; Jang EJ; Cho SK; Sung YK
    Arthritis Res Ther; 2021 Oct; 23(1):270. PubMed ID: 34706772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.
    Ni J; Qiu LJ; Hu LF; Cen H; Zhang M; Wen PF; Wang XS; Pan HF; Ye DQ
    Lupus; 2014 Mar; 23(3):284-92. PubMed ID: 24429300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The age-risk relationship of haematologic malignancies in female patients with systemic lupus erythematosus: a nationwide retrospective cohort study.
    Lin YC; Yen JH; Chang SJ; Lin YC
    Lupus; 2012 Oct; 21(11):1250-6. PubMed ID: 22740427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased incidence of cancer in systemic lupus erythematosus: a Finnish cohort study with more than 25 years of follow-up.
    Tallbacka KR; Pettersson T; Pukkala E
    Scand J Rheumatol; 2018 Nov; 47(6):461-464. PubMed ID: 29318934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the safety profile of calcineurin inhibitors: cancer risk in patients with systemic lupus erythematosus from the LUNA registry-a historical cohort study.
    Ichinose K; Sato S; Igawa T; Okamoto M; Takatani A; Endo Y; Tsuji S; Shimizu T; Sumiyoshi R; Koga T; Kawashiri SY; Iwamoto N; Tamai M; Nakamura H; Origuchi T; Yajima N; Sada KE; Miyawaki Y; Yoshimi R; Shimojima Y; Ohno S; Kajiyama H; Sato S; Fujiwara M; Kawakami A
    Arthritis Res Ther; 2024 Feb; 26(1):48. PubMed ID: 38347556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus.
    Ragnarsson O; Gröndal G; Steinsson K
    Lupus; 2003; 12(9):687-91. PubMed ID: 14514131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal Dependence and Cancer in Systemic Lupus Erythematosus.
    Cobo-Ibáñez T; Urruticoechea-Arana A; Rúa-Figueroa I; Martín-Martínez MA; Ovalles-Bonilla JG; Galindo M; Calvo-Alén J; Olivé A; Fernández-Nebro A; Menor-Almagro R; Tomero E; Horcada L; Uriarte-Itzazelaia E; Martínez-Taboada VM; Andreu JL; Boteanu A; Narváez J; Bohorquez C; Montilla C; Santos G; Hernández-Cruz B; Vela P; Salgado E; Freire M; Hernández-Beriain JÁ; Díez-Álvarez E; Expósito L; Fernández-Berrizbeitia O; Velloso-Feijoo ML; Ibáñez-Barceló M; Lozano-Rivas N; Bonilla G; Moreno M; Raya E; Quevedo-Vila VE; Vázquez-Rodríguez TR; Ibáñez-Ruan J; Muñoz-Fernández S; Sánchez-Alonso F; Pego-Reigosa JM
    Arthritis Care Res (Hoboken); 2020 Feb; 72(2):216-224. PubMed ID: 31529686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of systemic lupus erythematosus autoantibody diversity with breast cancer protection.
    Shah AA; Igusa T; Goldman D; Li J; Casciola-Rosen L; Rosen A; Petri M
    Arthritis Res Ther; 2021 Feb; 23(1):64. PubMed ID: 33632283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignancy in Pediatric-onset Systemic Lupus Erythematosus.
    Bernatsky S; Clarke AE; Zahedi Niaki O; Labrecque J; Schanberg LE; Silverman ED; Hayward K; Imundo L; Brunner HI; Haines KA; Cron RQ; Oen K; Wagner-Weiner L; Rosenberg AM; O'Neil KM; Duffy CM; von Scheven E; Joseph L; Lee JL; Ramsey-Goldman R
    J Rheumatol; 2017 Oct; 44(10):1484-1486. PubMed ID: 28765255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic lupus erythematosus and the risk of malignancy.
    Cibere J; Sibley J; Haga M
    Lupus; 2001; 10(6):394-400. PubMed ID: 11434573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancy in systemic lupus erythematosus.
    Abu-Shakra M; Gladman DD; Urowitz MB
    Arthritis Rheum; 1996 Jun; 39(6):1050-4. PubMed ID: 8651970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of cancer among female patients with systemic lupus erythematosus in Korea.
    Kang KY; Kim HO; Yoon HS; Lee J; Lee WC; Ko HJ; Ju JH; Cho CS; Kim HY; Park SH
    Clin Rheumatol; 2010 Apr; 29(4):381-8. PubMed ID: 20041274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus.
    Björnådal L; Löfström B; Yin L; Lundberg IE; Ekbom A
    Scand J Rheumatol; 2002; 31(2):66-71. PubMed ID: 12109649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.